Glassman Wealth Services’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-304
Closed -$9.68K 839
2023
Q4
$9.68K Sell
304
-174
-36% -$5.46K ﹤0.01% 892
2023
Q3
$16.9K Buy
478
+93
+24% +$3.54K ﹤0.01% 704
2023
Q2
$14.6K Buy
385
+33
+9% +$1.32K ﹤0.01% 705
2023
Q1
$13.3K Sell
352
-90
-20% -$3.46K ﹤0.01% 736
2022
Q4
$18.7K Buy
442
+131
+42% +$5.4K ﹤0.01% 679
2022
Q3
$10K Buy
311
+187
+151% +$6.57K ﹤0.01% 789
2022
Q2
$4K Sell
124
-97
-44% -$3.14K ﹤0.01% 1070
2022
Q1
$8K Buy
221
+9
+4% +$309 ﹤0.01% 893
2021
Q4
$8K Buy
212
+90
+74% +$3.75K ﹤0.01% 864
2021
Q3
$5K Buy
122
+22
+22% +$988 ﹤0.01% 959
2021
Q2
$4K Buy
100
+67
+203% +$2.59K ﹤0.01% 976
2021
Q1
$1K Sell
33
-107
-76% -$4.02K ﹤0.01% 1254
2020
Q4
$6K Buy
140
+95
+211% +$3.55K ﹤0.01% 829
2020
Q3
$2K Buy
45
+27
+150% +$976 ﹤0.01% 996
2020
Q2
$1K Buy
18
+6
+50% +$164 ﹤0.01% 1024
2020
Q1
$0 Hold
12
﹤0.01% 1286
2019
Q4
$0 Buy
+12
New +$262 ﹤0.01% 1286

Other funds holding GMAB

Glassman Wealth Services's GMAB Position: Q1 2024 in Review

Glassman Wealth Services sold out of Genmab (GMAB) in Q1 2024, closing a stake of 304 shares — an estimated $9.68K sold.

Glassman Wealth Services first reported a position in GMAB in Q4 2019 and held it in 17 quarters. The position peaked at $18.7K in Q4 2022. 227 funds tracked by Wall St. Rank hold GMAB as of Q1 2024.

  • Glassman Wealth Services reported no remaining Genmab position as of Q1 2024 after selling out during the quarter.
  • Glassman Wealth Services sold 304 Genmab shares in Q1 2024, an estimated $9.68K.
  • Glassman Wealth Services first reported a position in Genmab in Q4 2019 and held it in 17 quarters.
  • Glassman Wealth Services's Genmab position peaked at $18.7K in Q4 2022.
  • 227 funds tracked by Wall St. Rank held Genmab as of Q1 2024.

Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.